CAS 6556-11-2
:Inositol nicotinate
- 3-Pyridinecarboxylic acid, 1,2,3,4,5,6-cyclohexanehexayl ester
- Cyclohexane-1,2,3,4,5,6-Hexayl Hexapyridine-3-Carboxylate
- Dilcit
- Dilexpal
- Esantene
- Hamovannid
- Hexanicit
- Hexanicotinoyl inositol
- Hexanicotol
- Hexopal
- Inositol Hexanicotinate
- Inositol Nicotinate
- Inositol hexaniacinate
- Inositol, hexanicotinate, myo-
- Linodil
- Meso-inositol hexanicotinate
- Mesonex
- Mesotal
- Myo-Inositol Hexanicotinate
- Nicotinic acid, hexaester with myo-inositol
- Palohex
- Voir plus de synonymes
Inositol Niacinate
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C42H30N6O12Couleur et forme :Off-White PowderMasse moléculaire :810.19217myo-Inositol, hexa-3-pyridinecarboxylate
CAS :Formule :C42H30N6O12Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :810.7206myo-Inositol hexanicotinate
CAS :Formule :C42H30N6O12Degré de pureté :≥ 98.0%Couleur et forme :White to off-white powderMasse moléculaire :810.72Rel-(1R,2R,3S,4R,5S,6S)-Cyclohexane-1,2,3,4,5,6-Hexayl Hexanicotinate
CAS :Rel-(1R,2R,3S,4R,5S,6S)-Cyclohexane-1,2,3,4,5,6-Hexayl HexanicotinateDegré de pureté :97%Masse moléculaire :810.72g/molInositol nicotinate
CAS :Inositol nicotinate (Mesotal) has the effect of lowering cholesterol and expanding peripheral blood vessels for hypercholesterolemia and atherosclerosis.Formule :C42H30N6O12Degré de pureté :97.33%Couleur et forme :White PowderMasse moléculaire :810.72myo-Inositol Hexanicotinate
CAS :Produit contrôléApplications myo-Inositol Hexanicotinate is an nicotinate conjugate of myo-inositol, an structural basis for a number of secondary messengers.
References Harsha, K.P., et al.: J. Pharma. Res., 4, 217 (2011); Vilar, S., et al.: J. Med. Chem., 49, 1118 (2006);Formule :C42H30N6O12Couleur et forme :Off-WhiteMasse moléculaire :810.72Inositol nicotinate
CAS :Inositol nicotinate is a combination of two substances, inositol and nicotinate. It is used to reduce the risk of heart disease by lowering low-density lipoprotein-cholesterol (LDL) levels. Inositol nicotinate has been shown to increase the surface area of mitochondria, which may be due to its ability to inhibit the release of fatty acids from fat cells. Inositol nicotinate also increases magnesium levels in cells and induces mitochondrial functions. This drug has been tested in cell culture for its effects on skin cells and found that it can reduce the amount of x-linked adrenoleukodystrophy protein (XALD), a substance that accumulates in patients with X-linked adrenoleukodystrophy, an inherited disorder that causes progressive damage to the nervous system. The drugs also have been shown to have beneficial effects on cholesterol metabolism, reducing LDL cholesterol levels, as well as inhibiting platelet aggregation.
Formule :C42H30N6O12Degré de pureté :Min. 95%Couleur et forme :White PowderMasse moléculaire :810.72 g/mol










